HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma.

Abstract
The efficacy of preoperative neoadjuvant chemoradiotherapy (NAC) in cases of pancreatic cancer with extremely poor prognoses has been reported. In this study, we aimed to identify novel biomarkers that reflect prognoses following chemoradiotherapy using tertiary lymphoid organs (TLO) expressed in the tumor microenvironment. Resected tumor specimens were obtained from 140 pancreatic cancer patients. We retrospectively investigated the clinical relevance of TLO by categorizing patients into those who underwent upfront surgery (surgery first [SF]) and those who received NAC. The immunological elements within TLO were analyzed by immunohistochemistry (IHC). In the IHC analysis, the proportions of CD8+ T lymphocytes, PNAd+ high endothelial venules, CD163+ macrophages and Ki-67+ cells within the TLO were higher in the NAC group than in the SF group. In contrast, the proportion of programmed cell death-1+ immunosuppressive lymphocytes within TLO was lower in the NAC group than in the SF group. The NAC group demonstrated favorable prognoses compared with the SF group. In the multivariate analysis, the TLO/tumor ratio was determined as an independent predictive prognostic factor. In conclusion, the administration of preoperative chemoradiotherapy may influence the immunological elements in the tumor microenvironment and result in favorable prognoses in pancreatic ductal adenocarcinoma patients.
AuthorsShota Kuwabara, Takahiro Tsuchikawa, Toru Nakamura, Yutaka Hatanaka, Kanako C Hatanaka, Katsunori Sasaki, Masato Ono, Kazufumi Umemoto, Tomohiro Suzuki, Osamu Sato, Yuma Hane, Yoshitsugu Nakanishi, Toshimichi Asano, Yuma Ebihara, Yo Kurashima, Takehiro Noji, Soichi Murakami, Keisuke Okamura, Toshiaki Shichinohe, Satoshi Hirano
JournalCancer science (Cancer Sci) Vol. 110 Issue 6 Pg. 1853-1862 (Jun 2019) ISSN: 1349-7006 [Electronic] England
PMID30997706 (Publication Type: Journal Article)
Copyright© 2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Chemical References
  • Biomarkers, Tumor
Topics
  • Biomarkers, Tumor (immunology, metabolism)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Carcinoma, Pancreatic Ductal (immunology, surgery, therapy)
  • Chemoradiotherapy
  • Female
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Lymphoid Tissue (immunology, metabolism)
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Pancreatic Neoplasms (immunology, surgery, therapy)
  • Prognosis
  • Retrospective Studies
  • Tumor Microenvironment (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: